Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL134917 | 0.89 | — | — | |
| SCHEMBL5029470 | 0.87 | — | — | |
| Butane SCHEMBL11429688 | 0.78 | — | — | |
| Butane SCHEMBL3165890 | 0.78 | METAP1 (0.30) | — | |
| Butane SCHEMBL11580460 | 0.78 | — | — | |
| Butane SCHEMBL3405239 | 0.75 | — | — | |
| Butane SCHEMBL4577044 | 0.75 | — | — | |
| Butane SCHEMBL10797485 | 0.75 | — | — | |
| Butane SCHEMBL11583074 | 0.75 | CHRM1 (0.34) | — | |
| Butane SCHEMBL9163524 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114634700-B | Aerogel modified polyurethane foam heat insulation board and preparation method thereof | 重庆再升科技股份有限公司 | 2023-10-24 | — | — | CN | claimed |
| CN-116517129-A | Modified polyurethane foam heat insulation board and preparation method thereof | 唐宽 | 2023-08-01 | — | — | CN | claimed |
| CN-114634700-B | Aerogel modified polyurethane foam heat insulation board and preparation method thereof | 重庆再升科技股份有限公司 | 2023-10-24 | — | — | CN | disclosed |
| CN-116517129-A | Modified polyurethane foam heat insulation board and preparation method thereof | 唐宽 | 2023-08-01 | — | — | CN | disclosed |
| CN-114106038-A | Preparation method of hydroxyl phosphonate | 浙江万盛股份有限公司 | 2022-03-01 | — | — | CN | disclosed |
| EP-3521364-B1 | COPOLYMER COMPOSITION HAVING PHOSPHONATE GROUP | KURARAY CO (JP) | 2021-12-15 | — | — | EP | disclosed |
| EP-3521364-A1 | COPOLYMER COMPOSITION HAVING PHOSPHONATE GROUP | Kuraray Co., Ltd. (JP) | 2019-08-07 | — | — | EP | disclosed |
| US-20090029939-A1 | Pre-organized tricyclic integrase inhibitor compounds | GILEAD SCIENCES, INC. | 2009-01-29 | — | — | US | disclosed |
| US-20080076738-A1 | Phosphonate Analogs Of Hiv Integrase Inhibitor Compounds | GILEAD SCIENCES, INC. | 2008-03-27 | — | — | US | disclosed |
| US-7253180-B2 | Pre-organized tricyclic integrase inhibitor compounds | GILEAD SCIENCES, INC. (US) | 2007-08-07 | — | — | US | disclosed |
| EP-1742642-A2 | PHOSPHONATE ANALOGS OF HIV INTEGRASE INHIBITOR COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2007-01-17 | — | — | EP | disclosed |
| US-20060217410-A1 | Pre-organized tricyclic integrase inhibitor compounds | GILEAD SCIENCES, INC. | 2006-09-28 | — | — | US | disclosed |
| US-20060116356-A1 | Phosphonate analogs of HIV integrase inhibitor compounds | GILEAD SCIENCES, INC. | 2006-06-01 | — | — | US | disclosed |
| WO-2005117904-A2 | PHOSPHONATE ANALOGS OF HIV INTEGRASE INHIBITOR COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2005-12-15 | — | — | WO | disclosed |
| EP-1558613-A2 | PRE-ORGANIZED TRICYCLIC INTEGRASE INHIBITOR COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2005-08-03 | — | — | EP | disclosed |
| US-20040167124-A1 | Pre-organized tricyclic integrase inhibitor compounds | GILEAD SCIENCES, INC. | 2004-08-26 | — | — | US | disclosed |
| US-20040157804-A1 | Pre-organized tricyclic integrase inhibitor compounds | GILEAD SCIENCES, INC. | 2004-08-12 | — | — | US | disclosed |
| WO-2004035576-A2 | PRE-ORGANIZED TRICYCLIC INTEGRASE INHIBITOR COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2004-04-29 | — | — | WO | disclosed |
| WO-2004035577-A2 | PRE-ORGANIZED TRICYCLIC INTEGRASE INHIBITOR COMPOUNDS | GILEAD SCIENCES, INC. (US) | 2004-04-29 | — | — | WO | disclosed |
| US-4086208-A | Flame resistant polyesters | TOYO BOSEKI KABUSHIKI KAISHA (JA) | 1978-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060217410-A1 | Pre-organized tricyclic integrase inhibitor compounds | CCNI, INTS6, CCNE1 | HSD17B10 1054/4885TSHR 3906/4885 |
| US-20040167124-A1 | Pre-organized tricyclic integrase inhibitor compounds | INTS6, INTS9, MUS81 | HSD17B10 1502/4885TSHR 4025/4885 |
| US-20040157804-A1 | Pre-organized tricyclic integrase inhibitor compounds | INTS6, INTS9, MUS81 | HSD17B10 1502/4885TSHR 4025/4885 |
| US-20090029939-A1 | Pre-organized tricyclic integrase inhibitor compounds | MUS81, CDKL4, INTS6 | HSD17B10 1543/4885TSHR 3915/4885 |
| US-20060116356-A1 | Phosphonate analogs of HIV integrase inhibitor compounds | TYMP, PNP, PIKFYVE | HSD17B10 1111/4885TSHR 4778/4885 |
| US-20080076738-A1 | Phosphonate Analogs Of Hiv Integrase Inhibitor Compounds | TYMP, PNP, PIKFYVE | HSD17B10 1111/4885TSHR 4778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.